ABSTRACT SUBMISSION

Call for Abstracts

Lymphoma Symposium

The Lymphoma Symposium will be devoted to lymphoproliferations that present at specific locations, including immune-privileged and various extranodal sites.

  • Genetic changes
  • Microenviromental factors of importance for oncogenesis
  • Clinical behaviour

One part of the symposium will be dedicated to “Recent Advances” new and ground-breaking developments in lymphoma research will be discussed.

Bone Marrow Symposium

The Bone Marrow Symposium will be devoted to “Lymphoid proliferations in the bone marrow” (excluding small B-cell lymphomas)

Abstracts are welcome to be submitted on:

  • Features of bone marrow involvement in Hodgkin lymphoma, aggressive B-NHL and peripheral T-cell lymphomas
  • Non-neoplastic lymphoproliferations in the bone marrow (excluding immunodeficiency-related and EBV-associated lymphoproliferations)
  • The role of the bone marrow microenvironment in lymphoma manifestations

 

Important Dates

Submission deadline 1 May 2018

Notification of acceptance 29 June 2018

 

Preparation of Your Abstract

  • Abstracts must be submitted in English
  • All abstracts must contain original work that has not been published or presented on previous occasions
  • Titles must be as brief as possible but long enough to indicate clearly the nature of the study. Abbreviations must not be used in the title
  • The abstract should be structured into following parts: Background, Principles/Methodology, Results, Conclusion
  • Please indicate your preferred type of presentation (oral or poster) and choose a topic from the drop-down list
  • Please check spelling and grammar carefully. All abstracts will be published as submitted
  • Use generic names. Commercial drug names may not be used

Please note that the acceptance of your abstract does not include congress registration. We kindly ask for at least one author (the first or the presenting author) to register for the congress.

Contact the EAHP 2018 Organising Team for further information:

MCI Deutschland GmbH
MCI | Germany – Berlin
Markgrafenstr. 56
10117 Berlin
T: +49 30 204590
F: +49 30 2045950
eahp@mci-group.com